Ascendis Pharma A/S
ASND173.500USD
+6.720+4.03%
종가 07/31, 16:00（ET）시세는 15분 지연됩니다
10.58B시가총액
손실P/E TTM
자세한 내용은 Ascendis Pharma A/S 회사
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
회사 정보
종목 코드 ASND
회사 이름Ascendis Pharma A/S
상장일Jan 28, 2015
설립일2006
CEOMr. Jan Moller Mikkelsen
직원 수- -
유형Depository Receipt
회계 연도 종료Jan 28
주소Tuborg Boulevard 12
도시HELLERUP
증권 거래소NASDAQ Global Select Consolidated
국가Denmark
우편 번호2900
전화4570222244
웹사이트https://ascendispharma.dk/
종목 코드 ASND
상장일Jan 28, 2015
설립일2006
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
Mr. Mads Bodenhoff
Mr. Mads Bodenhoff
Senior Vice President, Head of Finance and Principal Accounting Officer
Senior Vice President, Head of Finance and Principal Accounting Officer
193.00
--
Mr. Donovan (Jay) Wu
Mr. Donovan (Jay) Wu
Executive Vice President, U.S. President
Executive Vice President, U.S. President
--
--
Dr. Aimee Shu,, M.D.
Dr. Aimee Shu,, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Mr. William Carl (Bill) Fairey, Jr.
Mr. William Carl (Bill) Fairey, Jr.
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
수익 분석
통화: EUR마지막 업데이트: Sun, Jul 6
통화: EUR마지막 업데이트: Sun, Jul 6
FY2025Q1
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
사업별EUR
이름
수익
비율
Commercial sale of products
96.03M
95.12%
Rendering of services
3.52M
3.49%
License
1.40M
1.39%
지역별EUR
이름
수익
비율
North America
73.69M
72.99%
Europe
21.33M
21.13%
Rest of world
5.94M
5.88%
사업별
지역별
사업별EUR
이름
수익
비율
Commercial sale of products
96.03M
95.12%
Rendering of services
3.52M
3.49%
License
1.40M
1.39%
주식 보유 통계
마지막 업데이트: Wed, Jul 23
마지막 업데이트: Wed, Jul 23
주주
주주 유형
주주
주주
비율
RA Capital Management, LP
17.03%
Westfield Capital Management Company, L.P.
9.08%
Avoro Capital Advisors LLC
8.64%
Janus Henderson Investors
7.43%
Fidelity Management & Research Company LLC
7.13%
Other
50.69%
주주
주주
비율
RA Capital Management, LP
17.03%
Westfield Capital Management Company, L.P.
9.08%
Avoro Capital Advisors LLC
8.64%
Janus Henderson Investors
7.43%
Fidelity Management & Research Company LLC
7.13%
Other
50.69%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
41.95%
Investment Advisor
39.67%
Venture Capital
17.38%
Hedge Fund
8.82%
Research Firm
4.70%
Individual Investor
0.78%
Family Office
0.44%
Family Office
0.44%
Pension Fund
0.36%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
499
70.49M
116.76%
-1.46M
2025Q1
513
68.89M
114.10%
-3.55M
2024Q4
488
67.37M
111.00%
-7.76M
2024Q3
475
65.25M
107.66%
-6.23M
2024Q2
459
63.44M
108.94%
-9.21M
2024Q1
453
63.54M
109.13%
-8.68M
2023Q4
430
62.90M
109.00%
-9.55M
2023Q3
414
62.85M
109.61%
-11.90M
2023Q2
426
63.03M
109.93%
-13.27M
2023Q1
427
63.10M
110.08%
-9.14M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
RA Capital Management, LP
10.28M
17.03%
+168.75K
+1.67%
Mar 31, 2025
Westfield Capital Management Company, L.P.
5.48M
9.08%
-48.98K
-0.89%
Mar 31, 2025
Avoro Capital Advisors LLC
5.22M
8.64%
+114.94K
+2.25%
Mar 31, 2025
Janus Henderson Investors
4.49M
7.43%
+106.57K
+2.43%
Mar 31, 2025
Fidelity Management & Research Company LLC
4.30M
7.13%
-52.57K
-1.21%
Mar 31, 2025
Artisan Partners Limited Partnership
4.26M
7.05%
-193.79K
-4.35%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
3.05M
5.06%
+328.28K
+12.04%
Mar 31, 2025
Capital International Investors
2.87M
4.76%
+11.54K
+0.40%
Mar 31, 2025
T. Rowe Price Associates, Inc.
2.26M
3.74%
-27.11K
-1.19%
Mar 31, 2025
MFS Investment Management
1.87M
3.1%
+9.63K
+0.52%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sun, Jul 6
마지막 업데이트: Sun, Jul 6
이름
비율
Harbor Health Care ETF
18.34%
AdvisorShares Dorsey Wright ADR ETF
2.58%
American Century Focused Dynamic Growth ETF
2.27%
BNY Mellon Innovators ETF
2.26%
Virtus LifeSci Biotech Products ETF
2.01%
Tema Heart & Health ETF
1.25%
ProShares Ultra Nasdaq Biotechnology
1.19%
Invesco Nasdaq Biotechnology ETF
1.11%
Main Thematic Innovation ETF
0.76%
Putnam Sustainable Future ETF
0.75%
더 보기
Harbor Health Care ETF
비율18.34%
AdvisorShares Dorsey Wright ADR ETF
비율2.58%
American Century Focused Dynamic Growth ETF
비율2.27%
BNY Mellon Innovators ETF
비율2.26%
Virtus LifeSci Biotech Products ETF
비율2.01%
Tema Heart & Health ETF
비율1.25%
ProShares Ultra Nasdaq Biotechnology
비율1.19%
Invesco Nasdaq Biotechnology ETF
비율1.11%
Main Thematic Innovation ETF
비율0.76%
Putnam Sustainable Future ETF
비율0.75%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
